Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M1 receptor:: Direct pharmacological evidence that AC-42 is an allosteric agonist

被引:86
作者
Langmead, CJ
Fry, VAH
Forbes, IT
Branch, CL
Christopoulos, A
Wood, MD
Herdon, HJ
机构
[1] GlaxoSmithKline Inc, Psychiat Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England
[2] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia
关键词
D O I
10.1124/mol.105.017814
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine hydrogen chloride (AC-42) is a selective agonist of the muscarinic M-1 receptor previously suggested to interact with an "ectopic" site on this receptor. However, the pharmacological properties of this site (i.e., whether it overlaps to any extent with the classic orthosteric site or represents a novel allosteric site) remain undetermined. In the present study, atropine or pirenzepine significantly inhibited the ability of either carbachol or AC-42 to stimulate inositol phosphate accumulation or intracellular calcium mobilization in Chinese hamster ovary (CHO) cells stably expressing the human M-1 receptor. However, the interaction between either of these antagonists and AC-42 was characterized by Schild slopes significantly less than unity. Increasing the concentrations of atropine revealed that the Schild regression was curvilinear, consistent with a negative allosteric interaction. More direct evidence for an allosteric mode of action of AC-42 was obtained in [H-3]N-methylscopolamine ([H-3]NMS) binding studies, in that both AC-42 and the prototypical modulator gallamine failed to fully inhibit specific [H-3] NMS binding in a manner that was quantitatively described by an allosteric model applied to both modulator data sets. Furthermore, AC-42 and gallamine significantly retarded the rate of [H-3] NMS dissociation from CHO-hM(1) cell membranes, conclusively demonstrating their ability to bind to a topographically distinct site to change M-1 receptor conformation. These data provide the first direct evidence that AC-42 is an allosteric agonist that activates M-1 receptors in the absence of the orthosteric agonist.
引用
收藏
页码:236 / 246
页数:11
相关论文
共 31 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   THE ALLOSTERIC ENHANCER, PD-81,723, STABILIZES HUMAN A(1)-ADENOSINE RECEPTOR COUPLING TO G-PROTEINS [J].
BHATTACHARYA, S ;
LINDEN, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1995, 1265 (01) :15-21
[3]   THE EFFECT OF MCN-A-343 ON MUSCARINIC RECEPTORS IN THE CEREBRAL-CORTEX AND HEART [J].
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC ;
STOCKTON, JM ;
ZIGMOND, MJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (02) :257-259
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Scintillation proximity assay of inositol phosphates in cell extracts: High-throughput measurement of G-protein-coupled receptor activation [J].
Brandish, PE ;
Hill, LA ;
Zheng, W ;
Scolnick, EM .
ANALYTICAL BIOCHEMISTRY, 2003, 313 (02) :311-318
[6]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[7]   Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors [J].
Christopoulos, A ;
Mitchelson, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 339 (2-3) :153-156
[8]   Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log [J].
Christopoulos, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (09) :351-357
[9]   Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3′-phthalimidopropyl) ammonium bromide (C7/3-phth) at cloned muscarinic acetylcholine receptors [J].
Christopoulos, A ;
Sorman, JL ;
Mitchelson, F ;
El-Fakahany, EE .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (02) :171-179
[10]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374